1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Global Insomnia Market - Market Research Analysis 2015-2019

Global Insomnia Market - Market Research Analysis 2015-2019

  • September 2015
  • -
  • Infiniti Research Limited
  • -
  • 62 pages

About insomnia
Insomnia or sleeplessness is characterized by the difficulty in falling asleep or remaining asleep, resulting in poor quality of sleep or little sleep. Sleeplessness can be acute or chronic. Work-related stress is the more common factor for acute or primary insomnia, while medical conditions, such as arthritis, or medicines, such as amphetamines, and substances, such as cocaine, are the common factors for chronic insomnia.

Technavio's analysts forecast the global insomnia market to decline at a CAGR of 3.08% over the period 2014-2019.

Covered in this report
The report includes the present scenario and the growth prospects of the global insomnia market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used for the treatment of insomnia.

Technavio's report, Global Insomnia Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA

Key Vendors
- Eisai
- Merck
- Pfizer
- Sanofi
- Takeda

Other prominent vendors
- Astellas
- Biocodex
- Dainippon Sumitomo
- ECR Pharmaceuticals (Valeant)
- Fidia Farmaceutici
- Flynn Pharma
- Johnson & Johnson
- Juste
- Meda

Key market driver
- Unmet medical needs
- For a full, detailed list, view our report

Key market challenge
- Dominance of generic products
- For a full, detailed list, view our report

Key market trend
- Emerging drugs targeting orexin receptors
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Insomnia Market - Market Research Analysis 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Insomnia: An overview
Introduction
Epidemiology
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Pipeline portfolio
Examples of pipeline candidates
PART 08: Market segmentation by type of formulation
Tablets
Capsules
Mist formulation
PART 09: Market segmentation by symptom
Market overview
Poor-quality sleep
Difficulties with sleep onset and/or maintenance
Others
PART 10: Geographical segmentation
Market overview
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
Competitive scenario
Market share analysis
Other prominent vendors
PART 17: Key vendor analysis
Eisai
Merck
Pfizer
Sanofi
Takeda
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global insomnia drugs market 2014-2019 ($ billions)
Exhibit 03: Key performance indicators of global insomnia drugs market
Exhibit 04: Five forces analysis
Exhibit 05: Pipeline portfolio
Exhibit 06: Market segmentation by type of formulation
Exhibit 07: Market segmentation by symptom
Exhibit 08: Geographical segmentation 2014
Exhibit 09: Global insomnia drugs market: Key drivers
Exhibit 10: Impact of drivers
Exhibit 11: Global insomnia drugs market: Key challenges
Exhibit 12: Impact of drivers and challenges
Exhibit 13: Global insomnia drugs market: Emerging trends
Exhibit 14: Lunesta sales in North America 2011-2014 ($ millions)
Exhibit 15: Lunesta sales in Japan 2013-2014 ($ millions)
Exhibit 16: Ambien: Global sales 2011-2014 ($ millions)
Exhibit 17: Ambien sales in Western Europe 2011-2014 ($ millions)
Exhibit 18: Ambien sales in the US 2011-2014 ($ millions)
Exhibit 19: Ambien sales in emerging markets 2011-2014 ($ millions)
Exhibit 20: Ambien sales in ROW 2011-2014 ($ millions)
Exhibit 21: Rozerem: Global sales 2011-2013 ($ millions)
Exhibit 22: Rozerem sales in Japan 2012-2014 ($ millions)
Exhibit 23: Takeda: Business segmentation by revenue 2015
Exhibit 24: Takeda: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 25: Takeda: Geographical segmentation by revenue 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Sleep Aids: Technologies and Global Markets

Sleep Aids: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Analyze the current market dynamics and evaluate the effect of strategic factors such as technology-driven change and industry consolidation of sleep aids and technologies. - Review ...

Sleeping Aids Market: By Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking) Product (Mattress & Pillow, Sleep Labs, Medication, Sleep Apena Devices) Medication (Prescription Based, OTC drugs, Herbal Drugs)-Forecast (2

Sleeping Aids Market: By Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking) Product (Mattress & Pillow, Sleep Labs, Medication, Sleep Apena Devices) Medication (Prescription Based, OTC drugs, Herbal Drugs)-Forecast (2

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Sleep aids are pills and medical devices that enable a person suffering from sleep disorder to fall asleep. Sleep aids consist of various products such as medications, sleep laboratories, sleep apnea devices, ...

Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020

Global Market Study on Sleep Aids: Sleep Apnea to Witness Highest Growth by 2020

  • $ 4900
  • Industry report
  • August 2016
  • by Persistence Market Research

Sleep aids are pills and medical devices which enable a person suffering from sleep disorder to fall asleep. They are used for diagnosis and treatment of sleep disorders and sleep disturbances. Sleep disorders ...

Consumer Health In The Us

September 2016 $ 2423

Consumer Health In Belgium

September 2016 $ 2423

Consumer Health In Austria

September 2016 $ 2423

Consumer Health In Canada

September 2016 $ 2423

Sleep Aids In Egypt

September 2016 $ 912

Sleep Aids In Morocco

September 2016 $ 912

Download Unlimited Documents from Trusted Public Sources

Sleep Aid Markets in Pakistan

  • August 2016
    9 pages
  • Sleep Aid  

  • Pakistan  

View report >

OTC Markets in the US

  • July 2016
    2 pages
  • OTC  

    Marketing Resea...  

    Dietary Supplem...  

  • United States  

View report >

Sleep Aid Markets in the US

  • June 2016
    9 pages
  • Sleep Aid  

    Cancer  

    Therapy  

  • United States  

View report >

Otc Markets In The Us

9 months ago

Otc Industry In The Us

9 months ago

Therapy Market In The Us

11 months ago

Related Market Segments :

Sleep Aid

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.